News

Press Releases

Pre-clinical Data to be Presented at The IASLC 16th World Conference On Lung Cancer

Dublin, Ireland, September 8, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer,...

Inflection Biosciences Announces Pre-clinical Data on IBL-202 to be Presented at IWCLL 2015

Dublin, Ireland, September 7, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer,...

Inflection Biosciences Shortlisted for Best Emerging Biotech at OBN Awards

Dublin, Ireland, September 2, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer,...

Inflection Biosciences Adds Renowned Experts to its Oncology Advisory Panel

Dublin, Ireland, August 5, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences Shortlisted for The Pharma Industry Awards 2015

Dublin, Ireland, July 29, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences’ Director of R&D Interviewed by Pharma Television

Dublin, Ireland, June 22, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Pre-clinical Data to be Presented at the 20th Congress of the European Hematology Association

Dublin, Ireland, June 9, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences to Present at 2015 BIO International Convention

Dublin, Ireland, June 8, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences to Present at BioEquity Europe 2015

Dublin, Ireland, May 12, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...

Inflection Biosciences to Present at BioTrinity 2015

Dublin, Ireland, April 27, 2015 – Inflection Biosciences Ltd, a private company developing highly innovative treatments for cancer, today...